Nusantara Sejahtera Raya Tbk. vs Merck Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp94 (market cap 7.75T, 189.9K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 500 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 4.6× Merck Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (189.9K versus 500). Which is the better fit depends on your goals.
| CNMA | MERK | |
|---|---|---|
Market Cap | 7.75T | 1.7T |
Volume | 189.9K | 500 |
Lot | 1.9K | 5 |
Turnover | 17.85M | 1.92M |
Average Price | 93.99 | 3,842 |
Value | 17.85M | 1.92M |
Indicative Equilibrium Price | 94 | 3,850 |
Indicative Equilibrium Volume | 1.17K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.
Read more on CNMA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →